Serum levels of Hsp72 and glucose were measured in five adolescents with type 1 diabetes mellitus (T1DM) prior to, during and following correction of severe DKA. Samples from nine relatively euglycemic T1DM patients served as controls.
DKA pre-treatment samples showed significant elevation in Hsp72 (40.8 ± 6.9 ng/ml) relative to euglycemic T1DM controls (33.6 ± 3.2 ng/ml) (P < 0.05). Treatment resulted in a decline in Hsp72 to control levels within 24 h, with Hsp72 and glucose levels being tightly correlated (r = 0.9258).
Extracellular Hsp72 is increased by DKA, paralleling changes in serum glucose levels.